CD28 and COVID-19: Consistent with these data, we found that COVID-19 was associated with attenuated production of IFN- γ after stimulation of peripheral blood mononuclear cells with agonistic antibodies against CD3/CD28, suggesting a defect in T cell function during COVID-19 as compared to healthy controls (Fig 6E).